-
Celator Surges 70% After Acquisition Announcement By Jazz Pharmaceuticals
Tuesday, May 31, 2016 - 8:28am | 364Read More...Shares of Celator Pharmaceuticals Inc (NASDAQ: CPXX) surged higher by more than 70 percent early Tuesday morning after the company has agreed to be acquired by Jazz Pharmaceuticals plc (NASDAQ: JAZZ) for approximately $1.5 billion, or $30.25 per share. Celator's stock closed for trading at...
-
Short Interest In Baxter International And Celator Pharmaceuticals Doubles
Thursday, May 12, 2016 - 8:52am | 747Read More...Short interest in a number of stocks surged in the most recent settlement period. Two healthcare stocks were among those leading that trend in the final weeks of April. Shares of both rose in the period, but only one held on to that gain. With the markets surging last month and the S&P 500...
-
Celator Pharmaceuticals See-Saws In Volatile Session
Monday, April 18, 2016 - 12:46pm | 336Read More...Shares of Celator Pharmaceuticals Inc (NASDAQ: CPXX) were highly volatile on Monday after the company detailed positive data for its lead product candidate, VYXEOS, during an industry conference. Shares of Celator opened for trading at $15.57 on Monday and quickly surged to a 52-week high of $...
-
StreetSweeper Negative On Celator, Said Good Story Won't Last
Monday, February 29, 2016 - 2:35pm | 334Read More...Shares of Celator Pharmaceuticals Inc (NASDAQ: CPXX) tumbled more than 3 percent on Monday after TheStreetSweeper's Sonya Colberg published a scathing report on the company. According to Colberg, the clinical-stage bio-pharmaceutical company has "finished cherry-picking and left the ladder against...
